Podcast Episodes
Back to Search
Episode 306: The Uromigos Paper of the Month - Chemo/Nivo as a bladder sparing approach in UC
Season 3 Episode 306
Matt Galsky describes his phase 2 study looking at gem/cis/nivo followed by nivo in responders. This potentially avoids cystectomy.
2 years, 7 months ago
Episode 305: FDA and Oncology Clinical Trials
Season 3 Episode 305
FDA Deputy Oncology Director Dan Suzman described approaches to oncology trials. Tom asks 3 last questions which annoys Brian more than usual.
2 years, 7 months ago
Episode 304: A PSMA CD3 Bispecific T-cell Engager in CRPC
Season 3 Episode 304
Tanya Dorff describes acapatamab, a prostate-specific membrane antigen (PSMA) CD3 bispecific engager.
2 years, 7 months ago
Episode 303: Community GU Oncology
Season 3 Episode 303
Michael Lattanzi discusses treatment plans and research in the community.
2 years, 7 months ago
Episode 302: Part 2- Adjuvant Therapy in solid tumors
Season 3 Episode 302
Hans Hammers discusses trial design and patient selection in the adjuvant setting.
2 years, 8 months ago
Episode 301: Cancer research from a global perspective.
Season 3 Episode 301
Vania Wisdom, editor of the Lancet, talks about approaches to cancer treatment and research in developing countries
2 years, 8 months ago
Episode 300: Adjuvant PD1 Therapy in Solid Tumours
Season 3 Episode 300
David McDermott discusses melanoma and renal data. We never get to bladder or lung.
2 years, 8 months ago
Episode 299: Androgen receptor ligand-directed degrader BMS-986365
Season 2 Episode 299
Dana Rathkopf describes phase 1 data for the androgen receptor ligand-directed degrader in prostate cancer
2 years, 8 months ago
Episode 298: ASCO GU 2024 Highlights
Season 2 Episode 298
Silke, Tom and Brian cover the bases.
2 years, 9 months ago
Episode 297: ASCO GU 2024: CONTACT2 Part 2 - The Aftermath
Season 2 Episode 297
Neeraj Agarwal addresses the issues raised at the meeting.
2 years, 9 months ago